ArticleInternational journal of molecular sciences2020

Anti-PD-1 Immunotherapy in Preclinical GL261 Glioblastoma: Influence of Therapeutic Parameters and Non-Invasive Response Biomarker Assessment with MRSI-Based Approaches.

Shuang Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.